PharmaJet

11:15 AM - 11:30 AM, Thursday, June 6, 2019 ・ Theater 1
Based in Golden, Colorado, PharmaJet’s mission is worldwide acceptance of PharmaJet Needle-Free devices as a standard of care in the vaccine delivery market. The PharmaJet Stratis® innovative Needle-Free Injector has U.S. FDA 510(k) marketing clearance, CE Mark and WHO PQS certification to deliver medications and vaccines intramuscularly or subcutaneously. In August 2014, the PharmaJet Stratis® Needle-Free Injector was approved for delivery of an influenza vaccine to deliver needle-free flu shots. The PharmaJet Tropis® device for intradermal injections received authorization to apply the CE Mark in May 2016. The PharmaJet Needle-Free Injectors are easy-to-use and eliminate needlestick injuries, needle reuse and cross contamination, and help reduce sharps waste disposal.
Ticker:
Not Provided.
Exchange:
Not Provided.
Company Type:
Company Website:
Company HQ State:
Colorado
Company HQ Country:
United States
Year Founded:
2005
Main Therapeutic Focus:
Lead Product in Development:
PharmaJet Tropis Needle-free injection system
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided.
Speaker
photo
Director of Scientific Affairs
PharmaJet